Washington, DC (December 2, 2025) — The American Pharmacists Association (APhA) today announced a major legislative victory secured for pharmacists and the patients they serve. Working closely with bipartisan members of Congress and collaborating with other health care stakeholders, APhA successfully secured language in recently passed opioid use disorder (OUD) legislation that empowers pharmacists to play a greater role in combating the opioid crisis and expands their ability to provide life-saving care.

Washington, DC (November 21, 2025) — The American Pharmacists Association (APhA) is pleased to announce the results of its 2025 Board of Trustees elections. Brandi Hamilton, PharmD, MS, BCPS, FAPhA, of Beverly Hills, CA, has been elected to serve as APhA President-elect for the 2026–2027 term. She will assume the role of APhA President for the 2027–2028 term. Kristen Snair, CPhT, MSJ, of Glendale, AZ, has been elected Pharmacy Technician Trustee for the 2026–2027 term—becoming only the second pharmacy technician in APhA history to serve on the Board of Trustees. 

WASHINGTON, D.C. (October 16, 2025) — Today, the Pharmacy-based Vaccine Access Work Group, consisting of representatives from a diverse group of 12 organizations across pharmacy practice settings, jointly published guiding principles for state policy on pharmacy personnel–administered vaccines. This marks an unprecedented level of collaboration between pharmacy professionals, symbolizing a strong commitment from the field of pharmacy to national public health interests.